A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a protein called CD22, which is found on the surface of B cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-epratuzumab tetraxetan is a type of radioimmunoconjugate.
Source: NCI Dictionary of Cancer Terms
Search the Glossary of Medical Terms
Newsletter
Sign up for the QuackTrack.org newsletter below!